CoChat

Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis

Open access
Saito, Makoto, Mansoor, Rashid, Kennon, Kalynn, Anvikar, Anupkumar R, Ashley, Elizabeth A, Chandramohan, Daniel, Cohee, Lauren M, D'Alessandro, Umberto, Genton, Blaise, Gilder, Mary Ellen, Juma, Elizabeth, Kalilani-Phiri, Linda, Kuepfer, Irene, Laufer, Miriam K, Lwin, Khin Maung, Meshnick, Steven R, Mosha, Dominic, Mwapasa, Victor, Mwebaza, Norah, Nambozi, Michael, Ndiaye, Jean-Louis A, Nosten, François, Nyunt, Myaing, Ogutu, Bernhards, Parikh, Sunil, Paw, Moo Kho, Phyo, Aung Pyae, Pimanpanarak, Mupawjay, Piola, Patrice, Rijken, Marcus J, Sriprawat, Kanlaya, Tagbor, Harry K, Tarning, Joel, Tinto, Halidou, Valéa, Innocent, Valecha, Neena, White, Nicholas J, Wiladphaingern, Jacher, Stepniewska, Kasia, McGready, Rose, Guérin, Philippe J · 2020 · The Lancet Infectious Diseases
Cited by 39

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Malaria in pregnancy affects both the mother and the fetus. However, evidence supporting treatment guidelines for uncomplicated (including asymptomatic) falciparum malaria in pregnant women is scarce and assessed in varied ways. We did a systematic literature review and individual patient data (IPD) meta-analysis to compare the efficacy and tolerability of different artemisinin-based or quinine-based treatments for malaria in pregnant women. METHODS: We did a systematic review of interventional or observational cohort studies assessing the efficacy of artemisinin-based or quinine-based treatments in pregnancy. Seven databases (MEDLINE, Embase, Global Health, Cochrane Library, Scopus, Web of Science, and Literatura Latino Americana em Ciencias da Saude) and two clinical trial registries (International Clinical Trials Registry Platform and ClinicalTrials.gov) were searched. The final search was done on April 26, 2019. Studies that assessed PCR-corrected treatment efficacy in pregnancy with follow-up of 28 days or more were included. Investigators of identified studies were invited to share data from individual patients. The outcomes assessed included PCR-corrected efficacy, PCR-uncorrected efficacy, parasite clearance, fever clearance, gametocyte development, and acute adverse events. One-stage IPD meta-analysis using Cox and logistic regression with random-effects was done to estimate the risk factors associated with PCR-corrected treatment failure, using artemether-lumefantrine as the reference. This study is registered with PROSPERO, CRD42018104013. FINDINGS: Of the 30 studies assessed, 19 were included, representing 92% of patients in the literature (4968 of 5360 episodes). Risk of PCR-corrected treatment failure was higher for the quinine monotherapy (n=244, adjusted hazard ratio [aHR] 6·11, 95% CI 2·57-14·54, p<0·0001) but lower for artesunate-amodiaquine (n=840, 0·27, 95% 0·14-0·52, p<0·0001), artesunate-mefloquine (n=1028, 0·56, 95% 0·34-0·94, p=0·03), and dihydroartemisinin-piperaquine (n=872, 0·35, 95% CI 0·18-0·68, p=0·002) than artemether-lumefantrine (n=1278) after adjustment for baseline asexual parasitaemia and parity. The risk of gametocyte carriage on day 7 was higher after quinine-based therapy than artemisinin-based treatment (adjusted odds ratio [OR] 7·38, 95% CI 2·29-23·82). INTERPRETATION: Efficacy and tolerability of artemisinin-based combination therapies (ACTs) in pregnant women are better than quinine. The lower efficacy of artemether-lumefantrine compared with other ACTs might require dose optimisation. FUNDING: The Bill & Melinda Gates Foundation, ExxonMobil Foundation, and the University of Oxford Clarendon Fund.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(20)30064-5

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 39

Metadata

Authors
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D'Alessandro, U., Genton, B., Gilder, M. E., Juma, E., Kalilani-Phiri, L., Kuepfer, I., Laufer, M. K., Lwin, K. M., Meshnick, S. R., Mosha, D., Mwapasa, V., Mwebaza, N., Nambozi, M., Ndiaye, J.-L. A., Nosten, F., Nyunt, M., Ogutu, B., Parikh, S., Paw, M. K., Phyo, A. P., Pimanpanarak, M., Piola, P., Rijken, M. J., Sriprawat, K., Tagbor, H. K., Tarning, J., Tinto, H., Valéa, I., Valecha, N., White, N. J., Wiladphaingern, J., Stepniewska, K., McGready, R., & Guérin, P. J.
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2020-08
Volume
20
Issue
8
Pages
943-952
ISSN
1473-3099 (ISSN-L)
OpenAlex
W3023795748
Cited by
39
References
18
FWCI
1.50
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis. https://app.cochat.ai/papers/10.1016/s1473-3099(20)30064-5
The paper
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D'Alessandro, U., Genton, B., Gilder, M. E., Juma, E., Kalilani-Phiri, L., Kuepfer, I., Laufer, M. K., Lwin, K. M., Meshnick, S. R., Mosha, D., Mwapasa, V., Mwebaza, N., . . . Guérin, P. J. (2020). Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(20)30064-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.